Premium
Dramatic Shift in the Infantile Hemangioma Treatment Paradigm at a Single Institution
Author(s) -
Gomulka Jennifer,
Siegel Dawn H.,
Drolet Beth A.
Publication year - 2013
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.12229
Subject(s) - medicine , infantile hemangioma , first line treatment , intensive care medicine , referral , single center , pediatrics , hemangioma , surgery , family medicine , chemotherapy
Abstract Historically the first line of treatment for infantile hemangiomas ( IH s) has been oral corticosteroids, but because of recent discoveries recognizing the effectiveness of oral and topical beta‐blockers, IH management is dynamically changing. With these new treatment options, some physicians are altering the way they manage IHs despite having little evidence‐based data on the treatment methods. Highlighting treatment changes at a single large tertiary pediatric referral center, we conclude that despite the numerous studies already published on this topic, more reliable prospective studies are needed to determine the safety, efficacy, and best treatment algorithms for the use of topical and oral beta‐blockers for the treatment of IHs.